MTOR and liver dysplastic nodule: Studies of mice with podocyte-specific mTOR activation induced by the conditional deletion of the upstream negative regulator TSC1 in podocytes recapitulated many features of DN, such as podocyte injury and loss, proteinuria, glomerular basement membrane thickening, mesangial expansion, and glomerulosclerosis [8].